Intensity Therapeutics, Inc.INTSNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+27.4%
5Y CAGR+23.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+27.4%/yr
Annual compound
5Y CAGR
+23.9%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $16.59M | +102.9% |
| 2023 | $8.17M | +8.2% |
| 2022 | $7.55M | -5.8% |
| 2021 | $8.01M | +28.8% |
| 2020 | $6.22M | +9.7% |
| 2019 | $5.68M | - |